38 related articles for article (PubMed ID: 8757979)
21. Pan-sarbecovirus mAb protects from variants.
Flemming A
Nat Rev Immunol; 2021 Sep; 21(9):547. PubMed ID: 34376832
[No Abstract] [Full Text] [Related]
22. Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures.
Haim H; Steiner I; Panet A
J Virol; 2007 Apr; 81(7):3525-34. PubMed ID: 17251303
[TBL] [Abstract][Full Text] [Related]
23. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
24. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.
Spenlehauer C; Kirn A; Aubertin AM; Moog C
J Virol; 2001 Mar; 75(5):2235-45. PubMed ID: 11160727
[TBL] [Abstract][Full Text] [Related]
25. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.
Nyambi PN; Gorny MK; Bastiani L; van der Groen G; Williams C; Zolla-Pazner S
J Virol; 1998 Nov; 72(11):9384-91. PubMed ID: 9765494
[TBL] [Abstract][Full Text] [Related]
26. Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1.
Armstrong SJ; McInerney TL; McLain L; Wahren B; Hinkula J; Levi M; Dimmock NJ
J Gen Virol; 1996 Dec; 77 ( Pt 12)():2931-41. PubMed ID: 9000083
[TBL] [Abstract][Full Text] [Related]
27. Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies.
McLain L; Dimmock NJ
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1457-60. PubMed ID: 8207410
[TBL] [Abstract][Full Text] [Related]
28. Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.
Vijh-Warrier S; Pinter A; Honnen WJ; Tilley SA
J Virol; 1996 Jul; 70(7):4466-73. PubMed ID: 8676471
[TBL] [Abstract][Full Text] [Related]
29. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
30. Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1.
Hioe CE; Hildreth JE; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):523-31. PubMed ID: 10221529
[TBL] [Abstract][Full Text] [Related]
31. Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp 120: identification of a very early fusion-independent event as a neutralization target.
Armstrong SJ; Dimmock NJ
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1397-402. PubMed ID: 8757979
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
